The FDA will launch a website this week that will publish the names of brand-name drugmakers that have been blocking generic competition by withholding product samples from generic drug companies through safety strategies with the FDA or distribution agreements. The move is part of the government's plan to tackle high drug prices, and FDA Commissioner Scott Gottlieb said the purpose of the website is to find out the cause of the problem, not to shame drugmakers.
FDA launches website to reveal drugmakers blocking generic competition
Sign up for ACG SmartBrief
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.